Octreotide inhibits the proliferation of gastric cancer cells through P300-HAT activity and the interaction of ZAC and P300

Wang,Liping; Huang,Xin; Chai,Yurong; Zou,Liyang; Chedrawe,Matthew; Ding,Yi

doi:10.3892/or.2017.5451

Octreotide inhibits the proliferation of gastric cancer cells through P300-HAT activity and the interaction of ZAC and P300

Authors:
- Liping Wang
- Xin Huang
- Yurong Chai
- Liyang Zou
- Matthew Chedrawe
- Yi Ding
View Affiliations

Affiliations: Department of Histology and Embryology, College of Basic Medical Sciences, Zhengzhou University, Zhengzhou, Henan 450001, P.R. China, Department of Psychology and Neuroscience, Faculty of Science, Dalhousie University, Halifax, Nova Scotia B3H 4R2, Canada
Published online on: February 14, 2017 https://doi.org/10.3892/or.2017.5451
Pages: 2041-2048

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Somatostatin (SST) exhibits a wide range of physiological functions, including the regulation of tumor cell growth. Octreotide (OCT) is a synthetic analogue of SST that can be used to slow gastrointestinal bleeding, inhibit the release of growth hormone and impede gastrointestinal tumor growth. The aim of the present study was to investigate the molecular mechanism of OCT underlying the inhibition of gastric cancer cell proliferation. Proteins of interest were detected using western blotting, and the zinc finger protein (ZAC)-P300 complex was quantified using co-immunoprecipitation. P300-histone acetyltransferase (P300-HAT) activity was determined spectrophotometrically. The results showed that OCT decreased the phosphorylation of Akt which caused the level of ZAC to increase. In turn, the interaction between ZAC and P300 increased the activity of P300-HAT; ultimately, the phosphorylation of serine 10 in histone H3 (pS10-H3) was decreased and the acetylation of lysine 14 in histone H3 (acK14-H3) was increased. These results suggest that OCT attenuates SGC-7901 cell proliferation by enhancing P300-HAT activity through the interaction of ZAC and P300, causing a reduction in pS10-H3 and an increase in acK14-H3. These findings provide insight for future research on OCT and further demonstrate the potential of OCT to be used as a therapeutic agent for gastric cancer.

View Figures

View References

1	Proietto M, Bianchi MM, Ballario P and Brenna A: Epigenetic and posttranslational modifications in light signal transduction and the circadian clock in Neurospora crassa. Int J Mol Sci. 16:15347–15383. 2015. View Article : Google Scholar : PubMed/NCBI
2	Banerjee T and Chakravarti D: A peek into the complex realm of histone phosphorylation. Mol Cell Biol. 31:4858–4873. 2011. View Article : Google Scholar : PubMed/NCBI
3	Seet BT, Dikic I, Zhou MM and Pawson T: Reading protein modifications with interaction domains. Nat Rev Mol Cell Biol. 7:473–483. 2006. View Article : Google Scholar : PubMed/NCBI
4	Edmunds JW and Mahadevan LC: MAP kinases as structural adaptors and enzymatic activators in transcription complexes. J Cell Sci. 117:3715–3723. 2004. View Article : Google Scholar : PubMed/NCBI
5	Izzo A and Schneider R: Chatting histone modifications in mammals. Brief Funct Genomics. 9:429–443. 2010. View Article : Google Scholar : PubMed/NCBI
6	Brazil DP and Hemmings BA: Ten years of protein kinase B signalling: A hard Akt to follow. Trends Biochem Sci. 26:657–664. 2001. View Article : Google Scholar : PubMed/NCBI
7	Tokunaga E, Oki E, Egashira A, Sadanaga N, Morita M, Kakeji Y and Maehara Y: Deregulation of the Akt pathway in human cancer. Curr Cancer Drug Targets. 8:27–36. 2008. View Article : Google Scholar : PubMed/NCBI
8	Varrault A, Ciani E, Apiou F, Bilanges B, Hoffmann A, Pantaloni C, Bockaert J, Spengler D and Journot L: hZAC encodes a zinc finger protein with antiproliferative properties and maps to a chromosomal region frequently lost in cancer. Proc Natl Acad Sci USA. 95:8835–8840. 1998. View Article : Google Scholar : PubMed/NCBI
9	Chen J and Li Q: Use of histone deacetylase inhibitors to examine the roles of bromodomain and histone acetylation in p300-dependent gene expression. Methods Mol Biol. 977:353–357. 2013. View Article : Google Scholar : PubMed/NCBI
10	Chen Lf, Fischle W, Verdin E and Greene WC: Duration of nuclear NF-kappaB action regulated by reversible acetylation. Science. 293:1653–1657. 2001. View Article : Google Scholar : PubMed/NCBI
11	Zhang X, Ouyang S, Kong X, Liang Z, Lu J, Zhu K, Zhao D, Zheng M, Jiang H, Liu X, et al: Catalytic mechanism of histone acetyltransferase p300: From the proton transfer to acetylation reaction. J Phys Chem B. 118:2009–2019. 2014.PubMed/NCBI
12	Li Z, Ding Y, Zhu Y, Yin M, Le X, Wang L, Yang Y and Zhang Q: Both gene deletion and promoter hyper-methylation contribute to the down-regulation of ZAC/PLAGL1 gene in gastric adenocarcinomas: A case control study. Clin Res Hepatol Gastroenterol. 38:744–750. 2014. View Article : Google Scholar : PubMed/NCBI
13	Florio T: Molecular mechanisms of the antiproliferative activity of somatostatin receptors (SSTRs) in neuroendocrine tumors. Front Biosci. 13:822–840. 2008. View Article : Google Scholar : PubMed/NCBI
14	Gatto F and Hofland LJ: The role of somatostatin and dopamine D₂ receptors in endocrine tumors. Endocr Relat Cancer. 18:R233–R251. 2011. View Article : Google Scholar : PubMed/NCBI
15	Zhang GZDY, Liu J, Le XP and Zhang QX: Correlation of ZAC with somatostatin and its receptor expression in gastric cancer tissues. Acta Anat Sinica. 39:703–707. 2008.
16	Dai W, Ding Y and Zhang QX: Role of ZAC gene in the pathway of octreotide inhibiting proliferation of gastric cancer cells in vitro. Acta Anat Sinica. 44:492–497. 2013.
17	Simboeck E, Sawicka A, Zupkovitz G, Senese S, Winter S, Dequiedt F, Ogris E, Di Croce L, Chiocca S and Seiser C: A phosphorylation switch regulates the transcriptional activation of cell cycle regulator p21 by histone deacetylase inhibitors. J Biol Chem. 285:41062–41073. 2010. View Article : Google Scholar : PubMed/NCBI
18	Winter S, Simboeck E, Fischle W, Zupkovitz G, Dohnal I, Mechtler K, Ammerer G and Seiser C: 14-3-3 proteins recognize a histone code at histone H3 and are required for transcriptional activation. EMBO J. 27:88–99. 2008. View Article : Google Scholar : PubMed/NCBI
19	Sawicka A and Seiser C: Histone H3 phosphorylation - a versatile chromatin modification for different occasions. Biochimie. 94:2193–2201. 2012. View Article : Google Scholar : PubMed/NCBI
20	Cheung P, Tanner KG, Cheung WL, Sassone-Corsi P, Denu JM and Allis CD: Synergistic coupling of histone H3 phosphorylation and acetylation in response to epidermal growth factor stimulation. Mol Cell. 5:905–915. 2000. View Article : Google Scholar : PubMed/NCBI
21	Clements A, Poux AN, Lo WS, Pillus L, Berger SL and Marmorstein R: Structural basis for histone and phosphohistone binding by the GCN5 histone acetyltransferase. Mol Cell. 12:461–473. 2003. View Article : Google Scholar : PubMed/NCBI
22	Lo WS, Trievel RC, Rojas JR, Duggan L, Hsu JY, Allis CD, Marmorstein R and Berger SL: Phosphorylation of serine 10 in histone H3 is functionally linked in vitro and in vivo to Gcn5-mediated acetylation at lysine 14. Mol Cell. 5:917–926. 2000. View Article : Google Scholar : PubMed/NCBI
23	Gao S, Yu BP, Li Y, Dong WG and Luo HS: Antiproliferative effect of octreotide on gastric cancer cells mediated by inhibition of Akt/PKB and telomerase. World J Gastroenterol. 9:2362–2365. 2003. View Article : Google Scholar : PubMed/NCBI
24	Theodoropoulou M, Zhang J, Laupheimer S, Paez-Pereda M, Erneux C, Florio T, Pagotto U and Stalla GK: Octreotide, a somatostatin analogue, mediates its antiproliferative action in pituitary tumor cells by altering phosphatidylinositol 3-kinase signaling and inducing Zac1 expression. Cancer Res. 66:1576–1582. 2006. View Article : Google Scholar : PubMed/NCBI
25	Hoffmann A, Barz T and Spengler D: Multitasking C₂H₂ zinc fingers link Zac DNA binding to coordinated regulation of p300-histone acetyltransferase activity. Mol Cell Biol. 26:5544–5557. 2006. View Article : Google Scholar : PubMed/NCBI
26	Theodoropoulou M, Stalla GK and Spengler D: ZAC1 target genes and pituitary tumorigenesis. Mol Cell Endocrinol. 326:60–65. 2010. View Article : Google Scholar : PubMed/NCBI
27	Arora A, Gera S, Maheshwari T, Raghav D, Alam MJ, Singh RK and Agarwal SM: The dynamics of stress p53-Mdm2 network regulated by p300 and HDAC1. PLoS One. 8:e527362013. View Article : Google Scholar : PubMed/NCBI
28	Wang F, Marshall CB and Ikura M: Transcriptional/epigenetic regulator CBP/p300 in tumorigenesis: Structural and functional versatility in target recognition. Cell Mol Life Sci. 70:3989–4008. 2013. View Article : Google Scholar : PubMed/NCBI
29	Soutoglou E, Viollet B, Vaxillaire M, Yaniv M, Pontoglio M and Talianidis I: Transcription factor-dependent regulation of CBP and P/CAF histone acetyltransferase activity. EMBO J. 20:1984–1992. 2001. View Article : Google Scholar : PubMed/NCBI
30	Dyson MH, Thomson S and Mahadevan LC: Heat shock, histone H3 phosphorylation and the cell cycle. Cell Cycle. 4:13–17. 2005. View Article : Google Scholar : PubMed/NCBI
31	Ray PD, Huang BW and Tsuji Y: Coordinated regulation of Nrf2 and histone H3 serine 10 phosphorylation in arsenite-activated transcription of the human heme oxygenase-1 gene. Biochim Biophys Acta. 1849:1277–1288. 2015. View Article : Google Scholar : PubMed/NCBI
32	Lieberman-Aiden E, van Berkum NL, Williams L, Imakaev M, Ragoczy T, Telling A, Amit I, Lajoie BR, Sabo PJ, Dorschner MO, et al: Comprehensive mapping of long-range interactions reveals folding principles of the human genome. Science. 326:289–293. 2009. View Article : Google Scholar : PubMed/NCBI
33	Andrulis ED, Neiman AM, Zappulla DC and Sternglanz R: Perinuclear localization of chromatin facilitates transcriptional silencing. Nature. 394:592–595. 1998. View Article : Google Scholar : PubMed/NCBI
34	Berman BP, Weisenberger DJ, Aman JF, Hinoue T, Ramjan Z, Liu Y, Noushmehr H, Lange CP, van Dijk CM, Tollenaar RA, et al: Regions of focal DNA hypermethylation and long-range hypomethylation in colorectal cancer coincide with nuclear lamina-associated domains. Nat Genet. 44:40–46. 2011. View Article : Google Scholar : PubMed/NCBI
35	Hansen KD, Timp W, Bravo HC, Sabunciyan S, Langmead B, McDonald OG, Wen B, Wu H, Liu Y, Diep D, et al: Increased methylation variation in epigenetic domains across cancer types. Nat Genet. 43:768–775. 2011. View Article : Google Scholar : PubMed/NCBI
36	Paska AV and Hudler P: Aberrant methylation patterns in cancer: A clinical view. Biochem Med. 25:161–176. 2015. View Article : Google Scholar
37	Berger SL: The complex language of chromatin regulation during transcription. Nature. 447:407–412. 2007. View Article : Google Scholar : PubMed/NCBI
38	Oliver SS and Denu JM: Dynamic interplay between histone H3 modifications and protein interpreters: Emerging evidence for a ‘histone language’. ChemBioChem. 12:299–307. 2011. View Article : Google Scholar : PubMed/NCBI
39	Winter S, Fischle W and Seiser C: Modulation of 14-3-3 interaction with phosphorylated histone H3 by combinatorial modification patterns. Cell Cycle. 7:1336–1342. 2008. View Article : Google Scholar : PubMed/NCBI
40	Ferjoux G, Bousquet C, Cordelier P, Benali N, Lopez F, Rochaix P, Buscail L and Susini C: Signal transduction of somatostatin receptors negatively controlling cell proliferation. J Physiol Paris. 94:205–210. 2000. View Article : Google Scholar : PubMed/NCBI